Beijing Tiantan Biologic. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Tiantan Biologic. with three other
companies in this sector in China:
China Biologic Products, Inc.
sales of 2.27 billion Chinese Renmimbi [US$329.55 million]
of which 100%
was Human Blood Product),
Tonghua Dongbao Medicines Company Limited
(2.03 billion Chinese Renmimbi [US$294.70 million]
of which 96%
was Pharmaceutical), and
Hualan Biological Engineering Inc
(1.93 billion Chinese Renmimbi [US$280.80 million]
of which 94%
was Blood Product).
Beijing Tiantan Biologic. reported sales of 2.10 billion Chinese Renmimbi (US$304.22 million)
December of 2016.
increase of 29.6%
versus 2015, when the company's sales were 1.62 billion Chinese Renmimbi.